Search Results 1771-1780 of 18457 for Immunode

1. A Study to Assess the Effectiveness and Safety of Durvalumab Alone or Combined with Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment - Mayo Clinic

   ... immunodeficiency virus (HIV; positive for HIV 1/2 antibodies). Active co-infection with both HBV and hepatitis D virus. Known allergy or hypersensitivity to ...

2. Consultative Gastroenterology - Overview - Mayo Clinic

   Certain people have an illness called common variable immunodeficiency, which predisposes them to getting more viral infections in the gut. And it's quite ...

3. Congenital Clinical Trials - Mayo Clinic Research

   These immune deficiency diseases are thought to be rare and include: Severe combined immunodeficiency (SCID), leukocyte adhesion deficiency (LAD), X-linked ...

4. Cabotegravir (oral route) - Side effects & dosage - Mayo Clinic

   Cabotegravir is used together with rilpivirine for short-term treatment of the human immunodeficiency virus type 1 (HIV-1) infection. HIV is the virus that ...

5. Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

   Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the ...

6. Cladribine (oral route) - Mayo Clinic

   Human immunodeficiency virus (HIV) infection or; Tuberculosis infection, chronic, active—Should not be used in patients with these conditions. Cancer ...

7. A Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies - Mayo Clinic

   Infection with human immunodeficiency virus (HIV) or chronic infection with hepatitis B virus (HBV) or hepatitis C virus (HCV). Patients with hepatitis B ...

8. Study Of DISC-0974 In Participants With Myelofibrosis Or Myelodysplastic Syndrome And Anemia - Mayo Clinic

   Hepatitis B or C, or human immunodeficiency virus (HIV) with detectable viral load 15. Uncontrolled fungal, bacterial, or viral infection (ongoing signs ...

9. Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer. - Mayo Clinic

   Significant liver cirrhosis defined as Child-Pugh Class B or C (Appendix 4). 15. Active infection with human immunodeficiency virus (HIV) except participants ...

10. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for ...